Boryung Pharm (003850) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion ≈ $33.18 Million USD) by net assets (₩818.35 Billion ≈ $554.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Boryung Pharm worth for the company's overall valuation and market capitalisation.

Boryung Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Boryung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency. Explore Boryung Pharm cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Suzhou Alton Electrical & Mechanical Industry Co. Ltd. SHE:301187	-0.070x
Zhejiang Tengen Electrics Co Ltd SHG:605066	N/A
Altice USA Inc NYSE:ATUS	-0.066x
Titan Machinery Inc NASDAQ:TITN	0.308x
Shandong Chenming Paper Holdings Ltd SHE:000488	-0.036x
Hunan Lead Power Dazhi Technology Inc Co SHE:300530	-0.195x
Sampoerna Agro Tbk JK:SGRO	0.034x
Cheryong Electric Co.Ltd KQ:033100	0.124x

Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)

The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. View Boryung Pharm share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩784.50 Billion ≈ $531.65 Million	₩80.56 Billion ≈ $54.59 Million	0.103x	+33.57%
2023-12-31	₩549.25 Billion ≈ $372.22 Million	₩42.22 Billion ≈ $28.61 Million	0.077x	+42.73%
2022-12-31	₩516.42 Billion ≈ $349.97 Million	₩27.81 Billion ≈ $18.85 Million	0.054x	-57.54%
2021-12-31	₩474.31 Billion ≈ $321.44 Million	₩60.17 Billion ≈ $40.77 Million	0.127x	-3.52%
2020-12-31	₩340.29 Billion ≈ $230.61 Million	₩44.74 Billion ≈ $30.32 Million	0.131x	-20.84%
2019-12-31	₩282.95 Billion ≈ $191.75 Million	₩47.00 Billion ≈ $31.85 Million	0.166x	+9.32%
2018-12-31	₩256.10 Billion ≈ $173.56 Million	₩38.91 Billion ≈ $26.37 Million	0.152x	+254.12%
2017-12-31	₩249.65 Billion ≈ $169.19 Million	₩-24.61 Billion ≈ $-16.68 Million	-0.099x	-305.69%
2016-12-31	₩195.35 Billion ≈ $132.39 Million	₩9.36 Billion ≈ $6.35 Million	0.048x	-61.98%
2012-12-31	₩145.79 Billion ≈ $98.80 Million	₩18.38 Billion ≈ $12.46 Million	0.126x	+89.34%
2011-12-31	₩137.97 Billion ≈ $93.50 Million	₩9.19 Billion ≈ $6.23 Million	0.067x	-62.35%
2010-12-31	₩136.41 Billion ≈ $92.44 Million	₩24.12 Billion ≈ $16.35 Million	0.177x	+510.22%
2009-12-31	₩124.01 Billion ≈ $84.04 Million	₩3.59 Billion ≈ $2.44 Million	0.029x	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$502.09 Million

₩740.89 Billion KRW

Market Cap Rank

#12278 Global

#344 in Korea

Share Price

₩8770.00

Change (1 day)

+2.10%

52-Week Range

₩7570.00 - ₩10680.00

All Time High

₩21257.60